PLJR965 Citations (5)
Originally described in: Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform.Rock JM, Hopkins FF, Chavez A, Diallo M, Chase MR, Gerrick ER, Pritchard JR, Church GM, Rubin EJ, Sassetti CM, Schnappinger D, Fortune SM Nat Microbiol. 2017 Feb 6;2:16274. doi: 10.1038/nmicrobiol.2016.274. PubMed Journal
Articles Citing PLJR965
| Articles |
|---|
| Human Kinase IGF1R/IR Inhibitor Linsitinib Controls the In Vitro and Intracellular Growth of Mycobacterium tuberculosis. Wang H, Bi J, Zhang Y, Pan M, Guo Q, Xiao G, Cui Y, Hu S, Chan CK, Yuan Y, Kaneko T, Zhang G, Chen S. ACS Infect Dis. 2022 Oct 14;8(10):2019-2027. doi: 10.1021/acsinfecdis.2c00278. Epub 2022 Sep 1. PubMed |
| PatA Regulates Isoniazid Resistance by Mediating Mycolic Acid Synthesis and Controls Biofilm Formation by Affecting Lipid Synthesis in Mycobacteria. Wang K, Deng Y, Cui X, Chen M, Ou Y, Li D, Guo M, Li W. Microbiol Spectr. 2023 Jun 15;11(3):e0092823. doi: 10.1128/spectrum.00928-23. Epub 2023 May 22. PubMed |
| TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infection. Stupar M, Tan L, Kerr ED, De Voss CJ, Forde BM, Schulz BL, West NP. Nat Commun. 2024 Feb 22;15(1):1615. doi: 10.1038/s41467-024-45343-7. PubMed |
| A pH-dependent direct sulfhydrylation pathway is required for the pathogenesis of Mycobacterium tuberculosis. Nain VK, Barik V, Pandey M, Pareek M, Sharma T, Pal R, Tyagi S, Bajpai M, Dwivedi P, Panda BN, Kumar Y, Asthana S, Pandey AK. Commun Biol. 2025 Apr 19;8(1):637. doi: 10.1038/s42003-025-08051-6. PubMed |
| Identification of a phenyl ester covalent inhibitor of caseinolytic protease and analysis of the ClpP1P2 inhibition in mycobacteria. Xiao G, Cui Y, Zhou L, Niu C, Wang B, Wang J, Zhou S, Pan M, Chan CK, Xia Y, Xu L, Lu Y, Chen S. mLife. 2025 Apr 15;4(2):155-168. doi: 10.1002/mlf2.12169. eCollection 2025 Apr. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.